LENZ

LENZ Therapeutics (LENZ)

About LENZ Therapeutics (LENZ)

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

Details

Daily high

$10.10

Daily low

$9.60

Price at open

$9.81

52 Week High

$50.40

52 Week Low

$8.25

Market cap

315.4M

Dividend yield

0.00%

Volume

640,401

Avg. volume

789,005

P/E ratio

-3.59

LENZ Therapeutics News